Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients

- Point-of-care tests can detect the hypercoagulable state related to obesity.
- The degree of obesity correlates with thromobelastometric/aggregometry parameters.
- Inflammatory markers significantly correlated with thromobelastometric/aggregometry parameters.
- POC rapidly assess the degree of hypercoagulability and hyperaggregability in obesity in whole blood.

IntroductionObesity has been associated with hypercoagulability and to increased risk of both arterial and venous thromboembolic events. Many different and complex changes in plasma coagulation factors have been described in patients with obesity. The aim of this case-control study is to evaluate hypercoagulability in a group of overweight and obese subjects by whole blood rotation thromboelastometry (ROTEM®) and impedance aggregometry (Multiplate®).MethodsROTEM® and Multiplate® analyses were performed in 80 subjects with a BMI ≥ 25 Kg/m2, of whom 20 overweight [BMI = 25-29.9 Kg/m2], 20 with I degree obesity [BMI = 30-34.9 Kg/m2], 20 with II degree obesity [BMI = 35-39.9 Kg/m2] and 20 with III degree [BMI > 40 Kg/m2] and compared with 80 age and gender-matched normal weight healthy individuals.ResultsThromboelastometry. In INTEM and EXTEM tests MCF and AUC were significantly increased in III degree obese compared with controls. MCF in FIBTEM was significantly higher in I, II and III degree obesity than controls (p = 0.027, 0.002 and < 0.001, respectively). Impedance aggregometry. A significant difference in platelet aggregation was found between III degree obese subjects and healthy controls in each of the tests considered. A significant correlation between FIBTEM-MCF and aggregometry parameters with BMI, waist circumference, leptin levels and high sensitive-C reactive proteins was also found.ConclusionsA relationship between hypercoagulability detected by whole blood thromboelastometry and aggregometry and increased fat mass is shown. Hypercoagulability also correlated with inflammatory markers. Point-of-care tests can be used to assess the degree of hypercoagulability and hyperaggregability in obese patients. Wider studies are needed to confirm our observations.